Antimicrobial Susceptibility Testing Market Growth Forecast 2025 To...

Antimicrobial Susceptibility Testing Market Growth Forecast 2025 To 2032

Posted 2026-03-10 03:55:29

Market Overview

Antimicrobial Susceptibility Testing (AST) refers to diagnostic procedures used to determine the efficacy of specific antimicrobial agents against bacterial, fungal, or other microbial pathogens. These tests are crucial for guiding clinicians in selecting the most appropriate antimicrobial therapy, thereby improving patient outcomes, and minimizing the development of antimicrobial resistance (AMR).AST methodologies include disk diffusion, automated instruments, agar dilution, E-test, and broth microdilution. The growing burden of infectious diseases, increasing prevalence of multidrug-resistant organisms, and global initiatives to combat AMR are significantly fueling the demand for advanced and accurate susceptibility testing tools.

Key Players

Thermo Fisher Scientific, BioMrieux, Becton Dickinson and Company BD, Danaher Corporation, Merck KGaA, Roche Diagnostics, Siemens Healthineers, Agilent Technologies, BioRad Laboratories, Bruker Corporation, Cepheid a subsidiary of Danaher Corporation, Accelerate Diagnostics, Liofilchem, HiMedia Laboratories, Creative Diagnostics, Zhuhai DL Biotech Co Ltd, Alifax Srl, ThermoGenesis Holdings Inc, Mast Group Ltd, Biolog Inc

Sample link - https://www.trendbridgeinsights.com/industry-report/antimicrobial-susceptibility-testing-market

Market segmentation:

Product Type

· Automated AST Systems

· Manual AST Systems

· Culture Media

· Consumables

· Accessories

Method

· Disk Diffusion

· Etest

· Broth Dilution

· Automated Test

· Molecular Testing

Application

· Clinical Diagnostics

· Drug Discovery and Development

· Epidemiology

· Environmental Monitoring

· Veterinary Diagnostics

End User

· Hospitals and Diagnostic Laboratories

· Pharmaceutical and Biotechnology Companies

· Research Institutes

· Contract Research Organizations

· Academic Institutes

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads AST market revenue due to strong healthcare systems and strict antimicrobial resistance surveillance. Europe follows with robust stewardship programs in Germany, France, and the UK. Asia-Pacific generates the highest production, driven by large-scale manufacturing in China and India, expanding diagnostic labs, pharmaceutical growth, and globally competitive AST kit and instrument exports.

Recent development :

In January 2025, Thermo Fisher Scientific announced a partnership with the U.S. Centers for Disease Control and Prevention (CDC) to improve antibiotic resistance surveillance through its Sensititre susceptibility plates. The initiative supports the global action plan on AMR through robust diagnostics and data-driven responses.

FAQ:

1 . What is the Forecasted market size & CAGR of the Antimicrobial Susceptibility Testing Market ?

As of 2023, the global Antimicrobial Susceptibility Testing Market was valued at approximately USD 3.7 billion, and it is projected to grow at a CAGR of 5.6%, reaching USD 3.9 billion by 2024 and approximately USD 5.1 billion by 2029.

2. Who are the leading manufacturers and suppliers in the Antimicrobial Susceptibility Testing Market ?

Thermo Fisher Scientific, BioMrieux, Becton Dickinson and Company BD, Danaher Corporation, Merck KGaA, Roche Diagnostics, Siemens Healthineers, Agilent Technologies

3. What are the upcoming trends of Antimicrobial Susceptibility Testing Market in the globe?

Automated AST Systems: AST workflows now incorporate automation systems to minimize human mistakes while boosting testing speed and shortening laboratory results delivery times. The AST market includes advanced systems from bioMérieux BD and Thermo Fisher Scientific which deliver quick and precise results to support fast clinical choices.

4. Which is the largest regional market for Antimicrobial Susceptibility Testing Market ?

The market revenue leadership currently belongs to North America because it has developed advanced healthcare systems, and many infectious diseases occur there while strict regulations in U.S. and Canada support antimicrobial resistance monitoring.

About US: